PNC Financial Services Group’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-3,245
Closed -$442K – 4165
2020
Q3
$442K Buy
3,245
+3,207
+8,439% +$341K ﹤0.01% 1420
2020
Q2
$3K Buy
38
+10
+36% +$834 ﹤0.01% 3744
2020
Q1
$2K Hold
28
– – ﹤0.01% 3776
2019
Q4
$2K Hold
28
– – ﹤0.01% 3839
2019
Q3
$2K Hold
28
– – ﹤0.01% 3891
2019
Q2
$2K Hold
28
– – ﹤0.01% 3907
2019
Q1
$2K Hold
28
– – ﹤0.01% 3910
2018
Q4
$2K Hold
28
– – ﹤0.01% 3901
2018
Q3
$2K Hold
28
– – ﹤0.01% 3992
2018
Q2
$2K Hold
28
– – ﹤0.01% 4016
2018
Q1
$2K Hold
28
– – ﹤0.01% 4079
2017
Q4
$2K Buy
+28
New +$1.08K ﹤0.01% 4041

PNC Financial Services Group's MYOK Position: Q4 2020 in Review

PNC Financial Services Group sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 3,245 shares — an estimated $442K sold.

PNC Financial Services Group first reported a position in MYOK in Q4 2017 and held it in 12 quarters. The position peaked at $442K in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • PNC Financial Services Group reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • PNC Financial Services Group sold 3,245 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $442K.
  • PNC Financial Services Group first reported a position in MyoKardia, Inc. Common Stock in Q4 2017 and held it in 12 quarters.
  • PNC Financial Services Group's MyoKardia, Inc. Common Stock position peaked at $442K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on PNC Financial Services Group's 13F filing for Q4 2020, filed 12 Feb 2021.